The integration of Artificial Intelligence (AI) in clinical trials has emerged as a transformative force in the United States healthcare system. While AI offers significant benefits in clinical trials, including cost reduction and improved efficiency, it also presents complex challenges in governance, regulation, and ethical implementation. Authors aim to analyze specific AI applications in U.S. clinical trials, focusing on case studies, regulatory frameworks, and ethical considerations.
Read More